Atlas Trials

Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease

Clinical trial NCT03890445 · COMPLETED

Trial details

NCT number
NCT03890445
Sponsor
Sandoz
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn´s Disease
Start date
2019-06-24
Primary completion
2020-05-08
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.